Direct and indirect consequences on gene expression of a thyroid hormone receptor alpha 1 mutation restricted to Sertoli cells

Molecular Reproduction and Development

Volumn 81, Issue 12, 2014, Pages 1159-1166

  Chatonnet, Fabrice ^a   Livera, Gabriel ^b   Fumel, Betty ^c   Fouchécourt, Sophie ^c   Flamant, Frédéric ^a  

^a UNIVERSITÉ LYON 1   (France)

^b Universite Paris Sud   (France)

^c UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR ALPHA 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GERM CELL; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RNA ISOLATION; RNA SEQUENCE; SERTOLI CELL; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL MODEL; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; SEQUENCE ANALYSIS; TIME; TRANSGENIC MOUSE;

MAMMALIA; MUS;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; MUTATION; SEQUENCE ANALYSIS, RNA; SERTOLI CELLS; THYROID HORMONE RECEPTORS ALPHA; TIME FACTORS;

EID: 84919957047     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.22437     Document Type: Article

References (26)

1. Ashida S, Furihata M, Katagiri T, Tamura K, Anazawa Y, Yoshioka H, Miki T, Fujioka T, Shuin T, Nakamura Y, Nakagawa H. 2006. Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression. Clin Cancer Res 12:2767-2773.
2. Chatonnet F, Flamant F, Morte B. 2014. A temporary compendium of thyroid hormone target genes in brain. Biochim Biophys Acta. S1874-939900137-0.
3. Chatonnet F, Guyot R, Benoit G, Flamant F. 2013. Genome-wide analysis of thyroid hormone receptors shared and specific functions in neural cells. Proc Natl Acad Sci U S A 110:E766-E775.
4. Chatonnet F, Guyot R, Picou F, Bondesson M, Flamant F. 2012. Genome-wide search reveals the existence of a limited number of thyroid hormone receptor alpha target genes in cerebellar neurons. PLoS One 7:e30703.
5. Ching T, Huang S, Garmire LX. 2014. Power analysis and sample size estimation for RNA-seq differential expression. Rna.
6. Cooke PS, Meisami E. 1991. Early hypothyroidism in rats causes increased adult testis and reproductive organ size but does not change testosterone levels. Endocrinology 129:237-243.
7. Fumel B, Guerquin MJ, Livera G, Staub C, Magistrini M, Gauthier C, Flamant F, Guillou F, Fouchecourt S. 2012. Thyroid hormone limits postnatal Sertoli cell proliferation in vivo by activation of its alpha1 isoform receptor (TRalpha1) present in these cells and by regulation of Cdk4/JunD/c-myc mRNA levels in mice. Biol Reprod 87:16, 1-9.
8. Holsberger DR, Kiesewetter SE, Cooke PS. 2005. Regulation of neonatal Sertoli cell development by thyroid hormone receptor alpha1. Biol Reprod 73:396-403.
9. Kalyanaraman H, Schwappacher R, Joshua J, et al. 2014. Nongenomic thyroid hormone signaling occurs through a plasma membrane-localized receptor. Sci Signal 7:ra48.
10. Kim E, Lee Y, Kim JS, Song BS, Kim SU, Huh JW, Lee SR, Kim SH, Hong Y, Chang KT. 2010. Extracellular domain of V-set and immunoglobulin domain containing 1 (VSIG1) interacts with sertoli cell membrane protein, while its PDZ-binding motif forms a complex with ZO-1. Mol Cells 30:443-448.
11. Kirby JD, Jetton AE, Cooke PS, Hess RA, Bunick D, Ackland JF, Turek FW, Schwartz NB. 1992. Developmental hormonal profiles accompanying the neonatal hypothyroidism-induced increase in adult testicular size and sperm production in the rat. Endocrinology 131:559-565.
12. Kulkarni YM, Liu C, Qi Q, Zhu Y, Klinke 2nd DJ, Liu J. 2013. Differential proteomic analysis of caveolin-1 KO cells reveals Sh2b3 and Clec12b as novel interaction partners of caveolin-1 and Capns1 as a potential mediator of caveolin-1-induced apoptosis. Analyst 138:6986-6996.
13. Lecureuil C, Fontaine I, Crepieux P, Guillou F. 2002. Sertoli and granulosa cell-specific Cre recombinase activity in transgenic mice. Genesis 33:114-118.
14. Lin JZ, Sieglaff DH, Yuan C, et al. 2013. Gene specific actions of thyroid hormone receptor subtypes. PLoS One 8:e52407.
15. Martin NP, Fernandez de Velasco EM, Mizuno F, Scappini EL, Gloss B, Erxleben C, Williams JG, Stapleton HM, Gentile S, Armstrong DL. 2014. A rapid cytoplasmic mechanism for PI3 kinase regulation by the nuclear thyroid hormone receptor, TRbeta, and genetic evidence for its role in the maturation of mouse hippocampal synapses in vivo. Endocrinology 155:3713-3724.
16. Mitic LL, Van Itallie CM, Anderson JM. 2000. Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol 279:G250-G254.
17. Quignodon L, Vincent S, Winter H, Samarut J, Flamant F. 2007. A point mutation in the activation function 2 domain of thyroid hormone receptor alpha1 expressed after CRE-mediated recombination partially recapitulates hypothyroidism. Mol Endocrinol 21:2350-2360.
18. Ramadoss P, Abraham BJ, Tsai L, Zhou Y, Costa-e-Sousa RH, Ye F, Bilban M, Zhao K, Hollenberg AN. 2014. Novel mechanism of positive versus negative regulation by thyroid hormone receptor beta1 (TRbeta1) identified by genome-wide profiling of binding sites in mouse liver. J Biol Chem 289:1313-1328.
19. Sanz E, Evanoff R, Quintana A, Evans E, Miller JA, Ko C, Amieux PS, Griswold MD, McKnight GS. 2013. RiboTag analysis of actively translated mRNAs in Sertoli and Leydig cells in vivo. PLoS One 8:e66179.
20. Sharpe RM, McKinnell C, Kivlin C, Fisher JS. 2003. Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 125:769-784.
21. Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH. 1997. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. Embo J 16:3965-3973.
22. Staud F, Cerveny L, Ahmadimoghaddam D, Ceckova M. 2013. Multidrug and toxin extrusion proteins (MATE/SLC47); role in pharmacokinetics. Int J Biochem Cell Biol 45:2007-2011.
23. van Haaster LH, de Jong FH, Docter R, de Rooij DG. 1993. High neonatal triiodothyronine levels reduce the period of Sertoli cell proliferation and accelerate tubular lumen formation in the rat testis, and increase serum inhibin levels. Endocrinology 133:755-760.
24. Wagner MS, Wajner SM, Maia AL. 2008. The role of thyroid hormone in testicular development and function. J Endocrinol 199:351-365.
25. Yen PM, Ando S, Feng X, Liu Y, Maruvada P, Xia X. 2006. Thyroid hormone action at the cellular, genomic and target gene levels. Mol Cell Endocrinol 246:121-127.
26. Yuan C, Lin JZ, Sieglaff DH, Ayers SD, Denoto-Reynolds F, Baxter JD, Webb P. 2012. Identical gene regulation patterns of T3 and selective thyroid hormone receptor modulator GC-1. Endocrinology 153:501-511.